Naphthalimide Nanoprobe with Enhanced Electron-Withdrawing Ability and Large Stokes Shift for NIR-II Fluorescence Imaging-Guided Phototheranostics
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c19915 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Min Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China. Hauptthemen laut MEDLINE: Naphthalimides, Optical Imaging, Fluorescent Dyes, Theranostic Nanomedicine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
ORCID-Profile: Meizhen Yin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Peng, M., Wei, H., Wang, Q., Guan, J., & Yin, M. (2025). Naphthalimide Nanoprobe with Enhanced Electron-Withdrawing Ability and Large Stokes Shift for NIR-II Fluorescence Imaging-Guided Phototheranostics. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c19915
Vancouver
Peng M, Wei H, Wang Q, Guan J, Yin M. Naphthalimide Nanoprobe with Enhanced Electron-Withdrawing Ability and Large Stokes Shift for NIR-II Fluorescence Imaging-Guided Phototheranostics. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c19915
BibTeX
@article{Peng2025,
author = {Peng, Min and Wei, Haoxuan and Wang, Qixuan and Guan, Jun and Yin, Meizhen},
title = {Naphthalimide Nanoprobe with Enhanced Electron-Withdrawing Ability and Large Stokes Shift for NIR-II Fluorescence Imaging-Guided Phototheranostics},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c19915}
}
EUVIMED